Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot3 - STU 1 Ballot 3 World

Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot3 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions

EvidenceVariable: Rate of Adverse Events of Special Interest (NCT03640312)

Official URL: https://fevir.net/resources/EvidenceVariable/367898 Version: 1.0.0-ballot3
Standards status: Informative Computable Name: Rate_of_Adverse_Events_of_Special_Interest_NCT03640312
Other Identifiers: FEvIR Object Identifier: FEvIR Object Identifier#367898, FEvIR Linking Identifier: NCT03640312-otherOutcome-2, OID:2.16.840.1.113883.4.642.40.44.24.181

Copyright/Legal: Copyright the Authors else Computable Publishing LLC. Noncommercial use permitted with CC BY-NC-SA 4.0 (https://creativecommons.org/licenses/by-nc-sa/4.0/). Commercial use permitted as agreed in Terms of Use (https://fevir.net/termsofuse).

Rate of pre-specified adverse events that are known side effects of active ingredients at the participant level.

version: 31; Last updated: 2026-09-08 12:21:25+0000

Profile: VariableDefinition

ArtifactPublicationStatus: Active

url: EvidenceVariable Rate of Adverse Events of Special Interest (NCT03640312)

identifier: FEvIR Object Identifier/367898, FEvIR Linking Identifier/NCT03640312-otherOutcome-2, Uniform Resource Identifier (URI)/urn:oid:2.16.840.1.113883.4.642.40.44.24.181

version: 1.0.0-ballot3

name: Rate_of_Adverse_Events_of_Special_Interest_NCT03640312

title: Rate of Adverse Events of Special Interest (NCT03640312)

citeAs:

Rate of Adverse Events of Special Interest (NCT03640312) [Database Entry: FHIR EvidenceVariable Resource]. Contributors: Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 367898. Revised 2026-09-08. Available at: https://fevir.net/resources/EvidenceVariable/367898. Computable resource at: https://fevir.net/resources/EvidenceVariable/367898#json.

status: Active

date: 2026-11-05 14:34:28+0000

author: Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter:

publisher: HL7 International / Clinical Decision Support

contact: HL7 International / Clinical Decision Support: http://www.hl7.org/Special/committees/dss

description:

Rate of pre-specified adverse events that are known side effects of active ingredients at the participant level.

copyright:

Copyright the Authors else Computable Publishing LLC. Noncommercial use permitted with CC BY-NC-SA 4.0 (https://creativecommons.org/licenses/by-nc-sa/4.0/). Commercial use permitted as agreed in Terms of Use (https://fevir.net/termsofuse).

Definitions

-Concept
*Rate of Adverse Events of Special Interest Rate of pre-specified adverse events that are known side effects of active ingredients at the participant level.

handling: Evidence variable handling not specified

Timings

-Text
*12 weeks